PubMed · 2005 · 26 citations · 30 references
MedicinePharmacotherapyPsychiatryChild PsychiatryNeuropsychiatryPediatric PharmacotherapyAttention DisordersAttention-deficit/hyperactivity DisorderNeurodevelopmental DisordersPediatric NeuropsychiatryPsychopharmacology In ChildrenTic DisordersAdhd PharmacotherapyAdhd Rating ScalesAdhd TreatmentOutcome MeasuresTic Disorder PharmacotherapyTic Disorders In ChildrenTic Severity AssessmentYale Global Tic Severity Scale
OBJECTIVES: To evaluate the efficacy and safety of guanfacine in children with attention-deficit hyperactivity disorder (ADHD) and tic disorders. MATERIAL AND METHOD: Twenty-five medication-free subjects (23 males and 2 females), aged 7-16 (mean = 10.6 +/- 2.0) years participated in an 8-week open-label guanfacine study. Subjects were recruited from a specialty clinic for children with tic disorders over a four-year period. Eligibility criteria included presence of ADHD (any type), a tic disorder (any type), and being medication free for two weeks. Outcome measures included the Hyperactivity Index of the Conners Parent Questionnaire, the teacher-rated ADHD Rating Scale, and the Yale Global Tic Severity Scale (YGTSS). RESULTS: All subjects met criteria for ADHD (combined type N = 22; predominantly inattentive type N = 3) and a tic disorder (Tourette's Disorder N = 20; chronic motor tic disorder N = 5). At an average dose of 2.0 +/- 0.6 mg/ day, guanfacine was associated with mean improvement of 27% on the Hyperactivity Index (N = 25; t = 4.61; p < 0.001), 32% on the total score of the teacher-rated ADHD Scale (N = 19; t = 5.27; p < 0.001), and 39% on the total tic severity scale (N = 19; t = 4.17; p < 0.001). Mild and statistically insignificant decreases in blood pressure and pulse were observed in the sample as a whole. Five subjects had endpoint systolic blood pressure below 1 SD from their age and gender norms. CONCLUSION: Results of this open-label study add to the growing data base on the safety and efficacy of guanfacine in children with ADHD and tic disorders.
30
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Julie M. Zito · JAMA · 2000 · 868 citations